UTAH
|
95-4545704
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
(I.R.S.
Employer
identification
no.)
|
305
NE 102ND AVENUE, SUITE 350
PORTLAND,
OREGON 97220
|
(503)
257-6700
|
|
(Address
of principal executive offices)
|
(Issuer’s
telephone number,
including
area code)
|
Check
whether the issuer (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for
such period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90
days.
|
Yes
x
No o
|
Indicate
by check mark whether the registrant is a shell company (as defined by
Rule 12b-2 of the Exchange Act)
|
Yes o No x
|
The
number of shares of the issuer’s Common Stock, par value $.001 per share,
outstanding as of June 20, 2008, was 891,745,161.
|
|
Transitional
Small Business Disclosure Format (Check one)
|
Yes o No x
|
PAGE
|
||
PART
I - FINANCIAL INFORMATION
|
1
|
|
ITEM
1. FINANCIAL STATEMENTS
|
1
|
|
CONDENSED
CONSOLIDATED BALANCE SHEET (Unaudited) At April 30,
2008
|
1
|
|
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the Six and Three
Months Ended April 30, 2008 and 2007 and for the Period From November 1,
2007 (Date of Commencement as a Development Stage Company) to April 30,
2008
|
2
|
|
CONDENSED
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY (Unaudited) For
the Six Months Ended April 30, 2008
|
4
|
|
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the Six Months
Ended April 30, 2008 and 2007 and for the Period From November 1, 2007
(Date of Commencement as a Development Stage Company) to April 30,
2008
|
10
|
|
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
|
13
|
|
ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OR PLAN OF
OPERATION
|
35
|
|
ITEM
3. CONTROLS AND PROCEDURES
|
45
|
|
PART
II - OTHER INFORMATION
|
46
|
|
ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF
PROCEEDS
|
46
|
|
ITEM
5. OTHER INFORMATION
|
47
|
|
ITEM
6. EXHIBITS
|
49
|
|
SIGNATURES
|
50
|
April
30,
2008
|
||||
ASSETS
|
||||
Current
Assets:
|
||||
Cash
|
$
|
1,621
|
||
Other
current assets
|
43,104
|
|||
Assets
of discontinued operations
|
120
|
|||
TOTAL
CURRENT ASSETS
|
44,845
|
|||
Property
and equipment - net
|
172,512
|
|||
Note
receivable
|
50,000
|
|||
Deferred
financing costs - net
|
674,054
|
|||
Other
assets
|
20,738
|
|||
TOTAL
ASSETS
|
$
|
962,149
|
||
LIABILITIES AND
STOCKHOLDERS’ DEFICIENCY
|
||||
Current
Liabilities:
|
||||
Convertible
notes payable
|
$
|
478,000
|
||
Notes
payable
|
200,000
|
|||
Convertible
debentures (net of debt discount of $2,823,307)
|
1,358,751
|
|||
Derivative
liabilities – warrants, options and embedded conversion
options
|
3,311,446
|
|||
Accounts
payable and accrued expenses
|
1,615,728
|
|||
Advance
from officer
|
49,000
|
|||
Liabilities
of discontinued operations
|
838
|
|||
TOTAL
CURRENT LIABILITIES
|
7,013,763
|
|||
TOTAL
LIABILITIES
|
7,013,763
|
|||
Commitments,
Contingencies and Other matters
|
||||
Stockholders’
Deficiency:
|
||||
Preferred
stock - $0.01 par value; Authorized - 15,000,000 shares; Issued - 0
shares;
Outstanding - 0
shares
|
-
|
|||
Common
stock - $0.001 par value; Authorized - 900,000,000 shares; Issued –
731,406,911 shares;
Outstanding – 730,907,057
shares
|
731,407
|
|||
Treasury
stock, at cost - 499,854 shares
|
(7,498
|
)
|
||
Additional
paid-in capital
|
89,765,774
|
|||
Unearned
compensation
|
(382,827
|
)
|
||
Accumulated
deficit at October 31, 2007
|
(90,689,341
|
)
|
||
Deficit
accumulated during the development stage
|
(5,469,129
|
)
|
||
TOTAL
STOCKHOLDERS’ DEFICIENCY
|
(6,051,614
|
)
|
||
TOTAL
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
|
$
|
962,149
|
For
the Six Months Ended
April
30,
|
Period
from
November
1, 2007
(Date
of
Commence-ment
as a
Development
Stage
Company) to
|
|||||||||||
2008
|
2007
|
April
30, 2008
|
||||||||||
OPERATING
EXPENSES:
|
||||||||||||
Acquired
in-process research and development
|
$
|
3,015,000
|
$
|
-
|
$
|
3,015,000
|
||||||
Amortization
of technology licenses and capitalized software
development costs
|
-
|
530,666
|
-
|
|||||||||
Research
and development expenses (including stock based
compensation of $23,932 and
$443,432, respectively)
|
550,257
|
809,620
|
550,257
|
|||||||||
Selling,
general and administrative expenses (including stock
based compensation of $1,173,025
and $1,058,791,
respectively)
|
3,059,996
|
2,847,234
|
3,059,996
|
|||||||||
TOTAL
OPERATING EXPENSES
|
6,625,253
|
4,187,520
|
6,625,253
|
|||||||||
OPERATING
LOSS
|
(6,625,253
|
)
|
(4,187,520
|
)
|
(6,625,253
|
)
|
||||||
OTHER
EXPENSES (INCOME):
|
||||||||||||
Interest
income
|
(1,345
|
)
|
-
|
(1,345
|
)
|
|||||||
Interest
expense
|
1,719,335
|
2,940,517
|
1,719,335
|
|||||||||
Change
in fair value of derivative liabilities
|
(3,123,293
|
)
|
(361,747
|
)
|
(3,123,293
|
)
|
||||||
Amortization
of deferred financing costs
|
253,947
|
1,165,847
|
253,947
|
|||||||||
Other
|
-
|
(27,895
|
)
|
-
|
||||||||
TOTAL
OTHER EXPENSES (INCOME)
|
(1,151,356
|
)
|
3,716,722
|
(1,151,356
|
)
|
|||||||
LOSS
FROM CONTINUING OPERATIONS
|
(5,473,897
|
)
|
(7,904,242
|
)
|
(5,473,897
|
)
|
||||||
INCOME
(LOSS) FROM DISCONTINUED OPERATIONS
|
4,768
|
(8,061
|
)
|
4,768
|
||||||||
NET
LOSS
|
$
|
(5,469,129
|
)
|
$
|
(7,912,303
|
)
|
$
|
(5,469,129
|
)
|
|||
BASIC
AND DILUTED NET LOSS PER COMMON SHARE
|
$
|
(0.01
|
)
|
$
|
(0.02
|
)
|
||||||
WEIGHTED
AVERAGE NUMBER OF COMMON SHARES
OUTSTANDING
|
545,462,176
|
410,318,226
|
For
the Three Months Ended
April
30,
|
||||||||
2008
|
2007
|
|||||||
OPERATING
EXPENSES:
|
||||||||
Acquired
in-process research and development
|
$
|
1,675,000
|
$
|
-
|
||||
Amortization
of technology licenses and capitalized software
development costs
|
-
|
270,363
|
||||||
Research
and development expenses (including stock based
compensation of $13,582 and
$23,022, respectively)
|
130,845
|
161,946
|
||||||
Selling,
general and administrative expenses (including stock based
compensation of $460,805 and
$589,382, respectively)
|
1,490,912
|
1,407,759
|
||||||
TOTAL
OPERATING EXPENSES
|
3,296,757
|
1,840,068
|
||||||
OPERATING
LOSS
|
(3,296,757
|
)
|
(1,840,068
|
)
|
||||
OTHER
EXPENSES (INCOME):
|
||||||||
Interest
income
|
(93
|
)
|
-
|
|||||
Interest
expense
|
604,197
|
154,016
|
||||||
Change
in fair value of derivative liabilities
|
(2,846,664
|
)
|
(1,900,394
|
)
|
||||
Amortization
of deferred financing costs
|
116,858
|
41,161
|
||||||
Other
|
-
|
(13,352
|
)
|
|||||
TOTAL
OTHER EXPENSES (INCOME)
|
(2,125,702
|
)
|
(1,718,569
|
)
|
||||
LOSS
FROM CONTINUING OPERATIONS
|
(1,171,055
|
)
|
(121,499
|
)
|
||||
INCOME
(LOSS) FROM DISCONTINUED OPERATIONS
|
(1,987
|
)
|
(320
|
)
|
||||
NET
LOSS
|
$
|
(1,173,042
|
)
|
$
|
(121,819
|
)
|
||
BASIC
AND DILUTED NET LOSS PER COMMON SHARE
|
$
|
(0.00
|
)
|
$
|
(0.00
|
)
|
||
WEIGHTED
AVERAGE NUMBER OF COMMON SHARES
OUTSTANDING
|
618,379,072
|
425,197,451
|
Common
Stock
|
Treasury
Stock
|
||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Additional
Paid-in
Capital
|
Unearned
Compensation
|
Accumulated
Deficit
|
Total
Stockholders’
Deficiency
|
||||||||||||||
Balance
at November 1, 2007
|
468,986,043
|
$
|
468,986
|
(499,854
|
)
|
$
|
(7,498
|
)
|
$
|
85,276,802
|
$
|
(907,656
|
)
|
$
|
(90,689,341
|
)
|
$
|
(5,858,707
|
)
|
||
Issuance
of common stock under service and consulting agreement on December 19,
2007 ($0.021 per share)
|
5,000,000
|
5,000
|
-
|
-
|
100,000
|
(105,000
|
)
|
-
|
-
|
||||||||||||
Issuance
of common stock under service and consulting agreements on December 20,
2007 ($0.021 per share)
|
1,000,000
|
1,000
|
-
|
-
|
20,000
|
(21,000
|
)
|
-
|
-
|
||||||||||||
Issuance
of common stock under service and consulting agreements on February 29,
2008 ($0.023 per share)
|
15,000,000
|
15,000
|
-
|
-
|
330,000
|
(345,000
|
)
|
-
|
-
|
||||||||||||
Issuance
of common stock for conversion of accrued interest on December
31, 2007 ($0.0179 per share)
|
1,295,944
|
1,296
|
-
|
-
|
21,837
|
-
|
-
|
23,133
|
|||||||||||||
Issuance
of common stock for cash on November 6, 2007 ($0.05 per
share)
|
400,000
|
400
|
-
|
-
|
19,600
|
-
|
-
|
20,000
|
|||||||||||||
Issuance
of common stock for cash on February 1, 2008 ($0.04 per
share)
|
950,000
|
950
|
-
|
-
|
37,050
|
-
|
-
|
38,000
|
Common
Stock
|
Treasury
Stock
|
|||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Additional
Paid-in
Capital
|
Unearned
Compensation
|
Accumulated
Deficit
|
Total
Stockholders’
Deficiency
|
|||||||||||||||
Issuance
of common stock for cash on February 15, 2008 ($0.04 per
share)
|
500,000
|
500
|
-
|
-
|
19,500
|
-
|
-
|
20,000
|
||||||||||||||
Issuance
of common stock for cash on February 21, 2008 ($0.04 per
share)
|
500,000
|
500
|
-
|
-
|
19,500
|
-
|
-
|
20,000
|
||||||||||||||
Issuance
of common stock for cash on March 19, 2008 ($0.04 per
share)
|
500,000
|
500
|
-
|
-
|
19,500
|
-
|
-
|
20,000
|
||||||||||||||
Issuance
of common stock for cash on April 4, 2008 ($0.01 per
share)
|
2,500,000
|
2,500
|
-
|
-
|
22,500
|
-
|
-
|
25,000
|
||||||||||||||
Issuance
of common stock for cash on April 9, 2008 ($0.01 per
share)
|
1,000,000
|
1,000
|
-
|
-
|
9,000
|
-
|
-
|
10,000
|
||||||||||||||
Issuance
of common stock for cash on April 11, 2008 ($0.01 per
share)
|
3,500,000
|
3,500
|
-
|
-
|
31,500
|
-
|
-
|
35,000
|
||||||||||||||
Issuance
of common stock for cash on April 15, 2008 ($0.01 per
share)
|
2,500,000
|
2,500
|
-
|
-
|
22,500
|
-
|
-
|
25,000
|
||||||||||||||
Issuance
of common stock for cash on April 28, 2008 ($0.01 per
share)
|
6,000,000
|
6,000
|
-
|
-
|
54,000
|
-
|
-
|
60,000
|
Common
Stock
|
Treasury
Stock
|
|||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Additional
Paid-in
Capital
|
Unearned
Compensation
|
Accumulated
Deficit
|
Total
Stockholders’
Deficiency
|
|||||||||||||||
Issuance
of common stock for conversion of convertible debentures and accrued
interest on February 29, 2008 ($0.0155 per share)
|
2,098,709
|
2,099
|
-
|
-
|
30,431
|
-
|
-
|
32,530
|
||||||||||||||
Issuance
of common stock for conversion of convertible debentures and accrued
interest on March 14, 2008 ($0.01617 per share)
|
673,698
|
674
|
-
|
-
|
10,220
|
-
|
-
|
10,894
|
||||||||||||||
Issuance
of common stock for conversion of convertible debentures and accrued
interest on March 18, 2008 ($0.01449 per share)
|
1,279,424
|
1,279
|
-
|
-
|
17,260
|
-
|
-
|
18,539
|
||||||||||||||
Issuance
of common stock for conversion of convertible debentures and accrued
interest on April 4, 2008 ($0.01022 per share)
|
996,113
|
996
|
-
|
-
|
9,184
|
-
|
-
|
10,180
|
||||||||||||||
Issuance
of common stock for conversion of accrued interest on April 4, 2008
($0.008925 per share)
|
465,574
|
466
|
-
|
-
|
3,689
|
-
|
-
|
4,155
|
||||||||||||||
Issuance
of common stock for conversion of accrued interest on April 8, 2008
($0.008925 per share)
|
138,138
|
138
|
-
|
-
|
1,095
|
-
|
-
|
1,233
|
Common
Stock
|
Treasury
Stock
|
|||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Additional
Paid-in
Capital
|
Unearned
Compensation
|
Accumulated
Deficit
|
Total
Stockholders’
Deficiency
|
|||||||||||||||
Issuance
of common stock for conversion of convertible debentures and accrued
interest on April 8, 2008 ($0.00945 per share)
|
1,062,551
|
1,062
|
-
|
-
|
8,978
|
-
|
-
|
10,040
|
||||||||||||||
Issuance
of common stock for conversion of convertible debentures and accrued
interest on April 9, 2008 ($0.00945 per share)
|
15,944
|
16
|
-
|
-
|
135
|
-
|
-
|
151
|
||||||||||||||
Issuance
of common stock for conversion of convertible debentures and accrued
interest on April 11, 2008 ($0.00917 per share)
|
1,111,845
|
1,112
|
-
|
-
|
9,084
|
-
|
-
|
10,196
|
||||||||||||||
Issuance
of common stock for conversion of convertible debentures and accrued
interest on April 14, 2008 ($0.0091 per share)
|
2,242,059
|
2,242
|
-
|
-
|
18,161
|
-
|
-
|
20,403
|
||||||||||||||
Issuance
of common stock for conversion of convertible debentures and accrued
interest on April 15, 2008 ($0.00903 per share)
|
1,129,932
|
1,130
|
-
|
-
|
9,073
|
-
|
-
|
10,203
|
||||||||||||||
Issuance
of common stock for conversion of convertible debentures and accrued
interest on April 21, 2008 ($0.0091 per share)
|
560,937
|
561
|
-
|
-
|
4,544
|
-
|
-
|
5,105
|
Common
Stock
|
Treasury
Stock
|
|||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Additional
Paid-in
Capital
|
Unearned
Compensation
|
Accumulated
Deficit
|
Total
Stockholders’
Deficiency
|
|||||||||||||||
Issuance
of common stock upon acquisition of BDSI on January 29, 2008 ($0.029 per
share)
|
60,000,000
|
60,000
|
-
|
-
|
1,680,000
|
-
|
-
|
1,740,000
|
||||||||||||||
Issuance
of common stock upon acquisition of MCCI on March 24, 2008 ($0.013167 per
share)
|
150,000,000
|
150,000
|
-
|
-
|
1,825,000
|
-
|
-
|
1,975,000
|
||||||||||||||
Stock
based compensation expense recognized for the granting and vesting of
options to employees and advisory board members
|
-
|
-
|
-
|
-
|
201,128
|
-
|
-
|
201,128
|
||||||||||||||
Reclassification
of warrants issued in connection with restricted common stock to
derivative liability
|
-
|
-
|
-
|
-
|
(142,563
|
)
|
-
|
-
|
(142,563
|
)
|
||||||||||||
Reclassification
of conversion option liability
|
-
|
-
|
-
|
-
|
39,429
|
-
|
-
|
39,429
|
||||||||||||||
Stock-based
compensation expense related to reset of conversion terms
|
-
|
-
|
-
|
-
|
37,637
|
-
|
-
|
37,637
|
Common
Stock
|
Treasury
Stock
|
|||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Additional
Paid-in
Capital
|
Unearned
Compensation
|
Accumulated
Deficit
|
Total
Stockholders’
Deficiency
|
|||||||||||||||
Amortization
of unearned compensation expense
|
-
|
-
|
-
|
-
|
-
|
995,829
|
-
|
995,829
|
||||||||||||||
Net
Loss
|
-
|
-
|
-
|
-
|
-
|
-
|
(5,469,129
|
)
|
(5,469,129
|
)
|
||||||||||||
Balance
at April 30, 2008
|
731,406,911
|
$
|
731,407
|
(499,854
|
)
|
$
|
(7,498
|
)
|
$
|
89,765,774
|
$
|
(382,827
|
)
|
$
|
(96,158,470
|
)
|
$
|
(6,051,614
|
)
|
Accumulated
deficit as of October 31, 2007
|
$
|
(90,689,341
|
)
|
|
Deficit
accumulated during the development stage
|
(5,469,129
|
)
|
||
Total
accumulated deficit as of April 30, 2008
|
$
|
(96,158,470
|
)
|
For
the Six Months Ended
April
30,
|
Period
from
November
1, 2007
(Date
of Commencement as a Development
Stage
Company) to
|
|||||||||||
2008
|
2007
|
April
30, 2008
|
||||||||||
CASH
FLOWS FROM OPERATING ACTIVITIES
|
||||||||||||
Net
loss from continuing operations
|
$
|
(5,473,897
|
)
|
$
|
(7,904,242
|
)
|
$
|
(5,473,897
|
)
|
|||
Adjustments
to reconcile net loss from continuing operations
to net cash used in operating
activities:
|
||||||||||||
Consulting
fees and other compensatory elements of stock
issuances
|
1,196,957
|
1,502,223
|
1,196,957
|
|||||||||
Change
in fair value of derivative liabilities
|
(3,123,293
|
)
|
(361,747
|
)
|
(3,123,293
|
)
|
||||||
Acquired
in-process research and development
|
3,015,000
|
-
|
3,015,000
|
|||||||||
Fair
value of warrants in excess of debt discount
|
369,721
|
-
|
369,721
|
|||||||||
Interest
expense related to reset of conversion rate on
convertible
debentures
|
37,637
|
-
|
37,637
|
|||||||||
Increase
in principal of convertible debentures in exchange for
extension of maturity
date
|
40,000
|
-
|
40,000
|
|||||||||
Amortization
of deferred financing costs
|
253,947
|
1,165,847
|
253,947
|
|||||||||
Amortization
of debt discount on notes
|
1,115,471
|
2,893,510
|
1,115,471
|
|||||||||
Amortization
of technology license and capitalized software
development fees
|
-
|
530,666
|
-
|
|||||||||
Depreciation
|
17,370
|
9,438
|
17,370
|
|||||||||
Other
non-cash expense
|
-
|
614
|
-
|
|||||||||
Change
in assets:
|
||||||||||||
Other
current assets
|
50,256
|
(52,779
|
)
|
50,256
|
||||||||
Other
assets
|
(2,256
|
)
|
-
|
(2,256
|
)
|
|||||||
Change
in liabilities:
|
||||||||||||
Accounts
payable and accrued expenses
|
(78,896
|
)
|
294,890
|
(78,896
|
)
|
|||||||
NET
CASH USED IN OPERATING ACTIVITIES
|
(2,581,983
|
)
|
(1,921,580
|
)
|
(2,581,983
|
)
|
||||||
CASH
FLOWS FROM INVESTING ACTIVITIES
|
||||||||||||
Proceeds
from sale of trademark rights
|
-
|
200,000
|
-
|
|||||||||
Proceeds
from maturity of short-term investments
|
-
|
1,000,000
|
-
|
|||||||||
Cash
acquired in connection with common stock issued upon
acquisition of
BDSI
|
400,000
|
-
|
400,000
|
|||||||||
Cash
acquired in connection with common stock issued upon
acquisition of
MCCI
|
300,000
|
-
|
300,000
|
|||||||||
Acquisition
and costs of capitalized software and development
fees
|
-
|
(526,787
|
)
|
-
|
||||||||
Acquisition
of property and equipment
|
(9,250
|
)
|
(112,419
|
)
|
(9,250
|
)
|
||||||
NET
CASH PROVIDED BY INVESTING ACTIVITIES
|
690,750
|
560,794
|
690,750
|
|||||||||
For
the Six Months Ended
April
30,
|
Period
from
November
1, 2007
(Date
of Commencement as a Development
Stage
Company) to
|
|||||||||||
2008
|
2007
|
April 30, 2008 | ||||||||||
CASH
FLOWS FROM FINANCING ACTIVITIES
|
||||||||||||
Proceeds
from issuance of common stock
|
273,000
|
300,000
|
273,000
|
|||||||||
Proceeds
from convertible debentures
|
3,175,000
|
-
|
3,175,000
|
|||||||||
Proceeds
from notes payable
|
-
|
300,000
|
-
|
|||||||||
Advance
from officer
|
49,000
|
-
|
49,000
|
|||||||||
Capitalized
financing costs
|
(345,000
|
)
|
(34,000
|
)
|
(345,000
|
)
|
||||||
Repayments
of notes payable
|
(1,300,000
|
)
|
-
|
(1,300,000
|
)
|
|||||||
NET
CASH PROVIDED BY FINANCING ACTIVITIES
|
1,852,000
|
566,000
|
1,852,000
|
|||||||||
DECREASE
IN CASH AND CASH EQUIVALENTS
FROM CONTINUING
OPERATIONS
|
(39,233
|
)
|
(794,786
|
)
|
(39,233
|
)
|
||||||
CASH
FLOWS FROM DISCONTINUED OPERATIONS
– OPERATING CASH
FLOWS
|
5,486
|
(8,061
|
)
|
5,486
|
||||||||
DECREASE
IN CASH
|
(33,747
|
)
|
(802,847
|
)
|
(33,747
|
)
|
||||||
CASH
– BEGINNING OF PERIOD
|
35,368
|
1,090,119
|
35,368
|
|||||||||
CASH
– END OF PERIOD
|
$
|
1,621
|
$
|
287,272
|
$
|
1,621
|
For
the Six Months Ended
April
30,
|
Period
from
November
1, 2007 (Date of Commencement as
Development
Stage
Company)
to
|
|||||||||||
2008
|
2007
|
April
30, 2008
|
||||||||||
Supplemental
Disclosure of Cash Flow Information:
|
||||||||||||
Cash
paid during the period for:
|
||||||||||||
Interest
|
$
|
31,833
|
$
|
50,000
|
$
|
31,833
|
||||||
Non-Cash
Investing and Financing Activities:
|
||||||||||||
Value
recorded as debt discount relating to warrants issued to
purchasers
of convertible
debentures
|
$
|
2,116,667
|
$
|
-
|
$
|
2,116,667
|
||||||
Value
assigned to conversion option liability in connection with
issuance
of convertible
debentures
|
$
|
1,058,333
|
$
|
-
|
$
|
1,058,333
|
||||||
Value
assigned to warrants issued in connection with notes
payable
|
$
|
-
|
$
|
226,567
|
$
|
-
|
||||||
Value
assigned on issuance date to warrants issued to finder
|
$
|
497,277
|
$
|
-
|
$
|
497,277
|
||||||
Common
stock issued for conversion of convertible debentures, notes
payable and accrued
interest
|
$
|
156,762
|
$
|
4,069,232
|
$
|
156,762
|
||||||
Issuance
of common stock upon exercise of stock options for the
settlement of vendor
payables
|
$
|
-
|
$
|
19,140
|
$
|
-
|
||||||
Common
stock issued for accrued liquidated damages
|
$
|
-
|
$
|
68,547
|
$
|
-
|
||||||
Reclassification
of derivative liability to equity upon exercise of options
|
$
|
-
|
$
|
71,521
|
$
|
-
|
||||||
Reclassification
of conversion option liability to equity
|
$
|
39,429
|
$
|
1,685,266
|
$
|
39,429
|
||||||
Issuance
of common stock upon acquisition of BDSI:
|
||||||||||||
Cash acquired
|
$
|
400,000
|
$
|
-
|
$
|
400,000
|
||||||
Acquired license to patented
technology (research and development)
|
1,340,000
|
-
|
1,340,000
|
|||||||||
Fair value of common stock issued
upon acquisition of BDSI
|
$
|
1,740,000
|
$
|
-
|
$
|
1,740,000
|
||||||
Issuance
of common stock upon acquisition of MCCI:
|
||||||||||||
Cash acquired
|
$
|
300,000
|
$
|
-
|
$
|
300,000
|
||||||
Acquired license to patented
technology (research and development)
|
1,675,000
|
-
|
1,675,000
|
|||||||||
Fair value of common stock issued
upon acquisition of MCCI
|
$
|
1,975,000
|
$
|
-
|
$
|
1,975,000
|
Three
Months Ended
April
30,
|
Six
Months Ended
April
30,
|
|||||||
2008
|
2007
|
2008
|
2007
|
|||||
Expected
dividends
|
None
|
None
|
None
|
None
|
||||
Expected
volatility
|
96.0
– 146.3%
|
47.9
- 134.1%
|
96.0
– 146.3%
|
47.9
- 136.9%
|
||||
Risk-free
interest rate
|
1.4
– 3.3%
|
4.6
- 5.0%
|
1.4
– 3.7%
|
4.6
- 5.2%
|
||||
Contractual
term (years)
|
0.2
- 8.3
|
0.4
- 9.3
|
0.2
- 8.5
|
0.4
- 9.5
|
Assets
and technology acquired:
|
||||
Cash
acquired
|
$ | 400,000 | ||
Acquired
license to patented technology (research and development)
|
1,340,000 | |||
Total assets and technology acquired
|
$ | 1,740,000 |
Cash
acquired
|
$
|
300,000
|
||
Acquired
license to patented technology (research and development)
|
1,675,000
|
|||
Total
assets and technology acquired
|
$
|
1,975,000
|
Deferred
financing costs
|
$
|
842,277
|
||
Less:
accumulated amortization
|
(168,223
|
)
|
||
Deferred
financing costs, net
|
$
|
674,054
|
Outstanding
Principal
Amount
|
Unamortized
Debt
Discount
|
Net
Carrying
Value
|
||||||||||
Current
|
$
|
3,527,778
|
$
|
2,823,188
|
$
|
704,590
|
Outstanding
Principal
Amount
|
Unamortized
Debt
Discount
|
Net
Carrying
Value
|
||||||||||
Current
|
$
|
600,000
|
$
|
--
|
$
|
600,000
|
Outstanding
Principal
Amount
|
Unamortized
Debt
Discount
|
Net
Carrying
Value
|
||||||||||
Current
|
$
|
4,280
|
$
|
119
|
$
|
4,161
|
Outstanding
Principal
Amount
|
Unamortized
Debt
Discount
|
Net
Carrying
Value
|
||||||||||
Current
|
$
|
50,000
|
$
|
--
|
$
|
50,000
|
·
|
issued
21,000,000 shares of restricted common stock in exchange for services
valued at $471,000;
|
·
|
issued
13,070,868 shares of common stock upon conversion of convertible
debentures with a principal amount of $117,000 and accrued interest of
$39,762;
|
·
|
issued
18,350,000 shares of restricted common stock in exchange for cash proceeds
of $273,000;
|
·
|
issued
60,000,000 shares of common stock valued at $1,740,000 upon acquisition of
BDSI; and
|
·
|
issued
150,000,000 shares of common stock valued at $1,975,000 upon acquisition
of MCCI.
|
·
|
Options
to purchase 500,000 shares of common stock were granted to three employees
under the 2006 Plan. These options were valued at $12,581 and have a ten
year term, an exercise price of $0.027 per share, and vest over a period
of approximately three years through January
2011;
|
·
|
Options
to purchase 250,000 shares of common stock were granted to an employee
under the 2006 Plan. These options were valued at $5,628 and have a ten
year term, an exercise price of $0.021 per share, and vest over a period
of approximately three years through December 2010;
and
|
·
|
Options
to purchase 2,000,000 shares of common stock were granted to a director
under the 2006 Plan. These options were valued at $57,827 and
have a ten year term, an exercise price of $0.031 per share, and vest over
a period of approximately three years through January
2011.
|
April
30,
2008
|
April
30,
2007
|
||||
Expected
dividends
|
None
|
None
|
|||
Expected
volatility
|
110%
|
|
116%
|
|
|
Risk-free
interest rate
|
3.88%
|
|
4.65%
|
|
|
Expected
life
|
10
years
|
10
years
|
As
of
|
|||
April
30,
2008
|
April
30,
2007
|
||
Warrants
to purchase common stock
|
320,356,095
|
117,870,937
|
|
2007
Debentures and accrued interest (1)
|
406,782,739
|
--
|
|
2006
Debentures and accrued interest (2)
|
64,608,285
|
9,822,118
|
|
Options
to purchase common stock
|
39,269,480
|
38,893,750
|
|
Convertible
notes payable and accrued interest
|
1,447,940
|
1,508,927
|
|
7%
Debentures and accrued interest
|
439,087
|
621,548
|
|
2005
Debentures and accrued interest (3)
|
979,298
|
120,685
|
|
Total
|
833,882,924
|
168,837,965
|
(1)
|
Based
on a ten day average closing bid price for the common stock discounted by
25% as of April 30, 2008 of
$0.0090.
|
(2)
|
Based
on a twenty day volume weighted average common stock price discounted by
30% as of April 30, 2008 and 2007 of $0.0089 and $0.06895,
respectively.
|
(3)
|
Based
on a five day volume weighted average common stock price discounted by 30%
as of April 30, 2008 and 2007 of $0.0085 and $0.06678,
respectively.
|
Common
stock issued in settlement of litigation
|
125,000,000
|
|||
Common
stock issued in exchange for cash proceeds
|
9,500,000
|
|||
Common
stock issued upon conversion of convertible
debentures
|
26,338,104
|
|||
Warrants
granted to purchase common stock
|
4,000,000
|
(i)
|
4,500,000
shares of common stock to three investors for total cash proceeds of
$45,000;
|
(ii)
|
1,185,712
shares of common stock to one investor upon conversion of 2006 Debentures
with a principal amount of $10,000 and interest of
$250;
|
(iii)
|
65,000,000
shares of common stock in settlement of two lawsuits with an investor
holding 2006 Debentures with an aggregate principal amount of $50,000;
and
|
(iv)
|
Warrants
to purchase 4,000,000 shares of common stock at an exercise price of $0.15
per share were granted to investors in connection with the issuance of
restricted common stock. The fair value of the stock warrants
estimated on the date of grant using the Black-Scholes model is $0.007 per
share or $28,008.
|
(i)
|
24,017,875
shares of common stock upon conversion of 2007 Debentures with a principal
amount of $62,791 and interest of
$14,795;
|
(ii)
|
1,134,517
shares of common stock upon conversion of 2006 Debentures with a principal
amount of $5,000 and interest of
$162;
|
(iii)
|
5,000,000
shares of restricted common stock in exchange for cash proceeds of
$75,000; and
|
(iv)
|
60,000,000
shares of restricted common stock in settlement of one lawsuit with an
investor holding 2006 Debentures with a principal amount of $25,000 and
interest of $786.
|